Abstract
BackgroundMyeloid-derived suppressor cells and tumor-associated macrophages inhibit anti-cancer immune responses systemically and in the tumor microenvironment, respectively, thereby limiting the efficacy of immune checkpoint blockers.1–5 However, the plasticity of myeloid...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have